These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 30888915)

  • 1. Gene Therapy Briefs.
    Philippidis A
    Hum Gene Ther Clin Dev; 2019 Mar; 30(1):1-4. PubMed ID: 30888915
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene and Cell Therapies: Inserm at the Heart of Biomedical Revolutions.
    Lévy Y
    Hum Gene Ther; 2016 Feb; 27(2):98-9. PubMed ID: 26886831
    [No Abstract]   [Full Text] [Related]  

  • 3. [Toward gene therapy for Friedreich ataxia-associated cardiomyopathy].
    Belbellaa B; Puccio H
    Med Sci (Paris); 2014 Oct; 30(10):842-5. PubMed ID: 25311016
    [No Abstract]   [Full Text] [Related]  

  • 4. Voyager's CNS gene therapy.
    Nat Biotechnol; 2019 Mar; 37(3):204. PubMed ID: 30833767
    [No Abstract]   [Full Text] [Related]  

  • 5. Laying the Foundation for Neuromuscular Disease Gene Therapy.
    Duan D
    Hum Gene Ther; 2020 Aug; 31(15-16):785-786. PubMed ID: 32640898
    [No Abstract]   [Full Text] [Related]  

  • 6. Friedreich's ataxia.
    Cooper JM; Bradley JL
    Int Rev Neurobiol; 2002; 53():147-73. PubMed ID: 12512339
    [No Abstract]   [Full Text] [Related]  

  • 7. [Association of Friedreich's disease and a parkinsonian syndrome in several patients in one family].
    CASTAIGNE P; CAMBIER J; CATHALA HP; AUGUSTIN P
    Rev Neurol (Paris); 1961 Nov; 105():452-4. PubMed ID: 13877145
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid and Complete Reversal of Sensory Ataxia by Gene Therapy in a Novel Model of Friedreich Ataxia.
    Piguet F; de Montigny C; Vaucamps N; Reutenauer L; Eisenmann A; Puccio H
    Mol Ther; 2018 Aug; 26(8):1940-1952. PubMed ID: 29853274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 150 years of Friedreich ataxia: from its discovery to therapy.
    Schulz JB; Pandolfo M
    J Neurochem; 2013 Aug; 126 Suppl 1():1-3. PubMed ID: 24024236
    [No Abstract]   [Full Text] [Related]  

  • 10. Friedreich ataxia: effects of genetic understanding on clinical evaluation and therapy.
    Lynch DR; Farmer JM; Balcer LJ; Wilson RB
    Arch Neurol; 2002 May; 59(5):743-7. PubMed ID: 12020255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-based approaches toward Friedreich ataxia therapeutics.
    Hebert MD; Whittom AA
    Cell Mol Life Sci; 2007 Dec; 64(23):3034-43. PubMed ID: 17828464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Friedreich ataxia.
    Bodensteiner JB
    Semin Pediatr Neurol; 2014 Jun; 21(2):72. PubMed ID: 25149926
    [No Abstract]   [Full Text] [Related]  

  • 13. [Friedreich ataxia. 3 years after the identification of the gene a glimmer of hope for therapy].
    von Kleist-Retzow JC; Chantrel-Groussard K; Rötig A; Munnich A; Rustin P
    Dtsch Med Wochenschr; 2000 Mar; 125(10):293-5. PubMed ID: 10742826
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical neurogenetics: friedreich ataxia.
    Collins A
    Neurol Clin; 2013 Nov; 31(4):1095-120. PubMed ID: 24176426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Abiotrophies.
    Br Med J; 1974 Mar; 1(5904):337-8. PubMed ID: 4274252
    [No Abstract]   [Full Text] [Related]  

  • 16. A review of Friedreich ataxia clinical trial results.
    Perlman SL
    J Child Neurol; 2012 Sep; 27(9):1217-22. PubMed ID: 22927692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of the GAA repeats from the human frataxin gene using the CRISPR-Cas9 system in YG8R-derived cells and mouse models of Friedreich ataxia.
    Ouellet DL; Cherif K; Rousseau J; Tremblay JP
    Gene Ther; 2017 May; 24(5):265-274. PubMed ID: 28024081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial correction of sensitivity to oxidant stress in Friedreich ataxia patient fibroblasts by frataxin-encoding adeno-associated virus and lentivirus vectors.
    Fleming J; Spinoulas A; Zheng M; Cunningham SC; Ginn SL; McQuilty RC; Rowe PB; Alexander IE
    Hum Gene Ther; 2005 Aug; 16(8):947-56. PubMed ID: 16076253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of the neurodegenerative disorders.
    Martin JB
    N Engl J Med; 1999 Jun; 340(25):1970-80. PubMed ID: 10379022
    [No Abstract]   [Full Text] [Related]  

  • 20. Friedreich ataxia: an update on animal models, frataxin function and therapies.
    González-Cabo P; Llorens JV; Palau F; Moltó MD
    Adv Exp Med Biol; 2009; 652():247-61. PubMed ID: 20225031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.